Research Output per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 4 Similar Profiles
Schizophrenia
Medicine & Life Sciences
Antipsychotic Agents
Medicine & Life Sciences
olanzapine
Medicine & Life Sciences
Psychotic Disorders
Medicine & Life Sciences
Risperidone
Medicine & Life Sciences
Haloperidol
Medicine & Life Sciences
Clozapine
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1978 2019
34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities
Anderson, K. E., Stamler, D., Davis, M. D., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In : CNS spectrums. 24, 1, 1 p.Research output: Contribution to journal › Article
Open Access
Dopamine Antagonists
Comorbidity
Psychotic Disorders
Psychiatry
Mood Disorders
35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia
Anderson, K. E., Stamler, D., Davis, M. D., Gross, N., Hauser, R. A., Jarskog, L. F., Jimenez-Shahed, J., Kumar, R., Ochudlo, S., McEvoy, J. P. & Fernandez, H. H., Feb 1 2019, In : CNS spectrums. 24, 1, p. 193-194 2 p.Research output: Contribution to journal › Article
Open Access
Placebos
Therapeutics
Dyskinesias
deutetrabenazine
Tardive Dyskinesia
Characterizing treatment effects of valbenazine for tardive dyskinesia: Additional results from the KINECT 3 study
Correll, C. U., Cutler, A. J., Kane, J. M., McEvoy, J. P., Liang, G. S. & O'Brien, C. F., Jan 1 2019, In : Journal of Clinical Psychiatry. 80, 1Research output: Contribution to journal › Article
Placebos
Body Regions
Diagnostic and Statistical Manual of Mental Disorders
Therapeutics
Odds Ratio
The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders
McEvoy, J. P., Park, T., Schilling, T., Terasawa, E., Ayyagari, R. & Carroll, B., Jan 1 2019, In : Current Medical Research and Opinion.Research output: Contribution to journal › Article
Mental Disorders
Antipsychotic Agents
Inpatients
Delivery of Health Care
Tardive Dyskinesia
Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women with Psychosis: Results from the DAAMSEL Clinical Trial
Kelly, D. L., Powell, M. M., Wehring, H. J., Sayer, M. A., Kearns, A. M., Hackman, A. L., Buchanan, R. W., Nichols, R. B., Adams, H. A., Richardson, C. M., Vyas, G., McMahon, R. P., Earl, A. K., Sullivan, K. M., Liu, F., Luttrell, S. E., Dickerson, F. B., Feldman, S. M., Narang, S., Koola, M. M. & 3 others, Aug 1 2018, In : Journal of Clinical Psychopharmacology. 38, 4, p. 317-326 10 p.Research output: Contribution to journal › Article
Prolactin
Psychotic Disorders
Clinical Trials
Placebos
Galactorrhea